Results 231 to 240 of about 29,657 (272)
Some of the next articles are maybe not open access.
Treating carbapenem-resistant Acinetobacter baumannii infections
The Lancet Infectious Diseases, 2023Not required for the type of ...
Giannella M., Viale P.
openaire +3 more sources
Contamination of healthcare environment by carbapenem-resistant Acinetobacter baumannii
The American Journal of the Medical Sciences, 2022Acinetobacter baumannii is frequently found on floors, devices, and environmental sites in hospitals and can survive for prolonged periods and accumulate resistance determinants. The infection and presence of carbapenem-resistant A. baumannii (CRAB) in patients is associated with increased mortality, severe clinical outcomes, and longer lengths of stay
Flora, Cruz-López +5 more
openaire +2 more sources
The Rise of Carbapenem-Resistant Acinetobacter baumannii
Current Pharmaceutical Design, 2012Acinetobacter spp. are Gram-negative bacteria that have become one of the most difficult pathogens to treat. The species A. baumannii, largely unknown 30 years ago, has risen to prominence particularly because of its ability to cause infections in immunocompromised patients.
Evans, Benjamin A. +2 more
openaire +3 more sources
Carbapenem-Resistant Acinetobacter baumannii Recovered from Swine Manure
Microbial Drug Resistance, 2019Recently, concerns have been raised about the possibility of Acinetobacter baumannii transmission between animals and humans. So far, A. baumannii has been reported in animals with which people can come into contact. The presence of this pathogen in animal manure presents an equally important public health risk.
Hrenović, Jasna +5 more
openaire +3 more sources
Epidemiology of carbapenem resistant Acinetobacter baumannii in New Zealand
New Zealand Medical Journal, 2022Carbapenem resistant Acinetobacter baumannii have limited treatment options and a propensity to cause hospital outbreaks. In recent years an increase in their detection has been observed in New Zealand. This study aimed to describe the molecular epidemiology of these isolates.This study utilised carbapenem resistant A.
Matthew R, Blakiston +5 more
openaire +2 more sources
Investigation of carbapenem resistant Acinetobacter baumannii ST2 in Iran
Acta Microbiologica et Immunologica Hungarica, 2021AbstractThis study investigated carbapenem resistance among Acinetobacter baumannii isolated from respiratory specimens. Epidemiological relationship of the isolates was also evaluated. In this study, 81 respiratory specimens of A. baumannii from AL Zahra Hospital were confirmed by phenotypic and genotypic methods.
Aliakbar Rezaei +2 more
openaire +3 more sources
Carbapenem-resistantAcinetobacter baumannii: epidemiology, surveillance and management
Expert Review of Anti-infective Therapy, 2013Carbapenem-resistant Acinetobacter baumannii pose a significant threat to hospitalized patients, as therapeutic options are scarse. Alarmingly, rates of carbapenem-resistance in A. baumannii are on the rise and are slowly becoming a routine phenotype for this organism.
Jason M, Pogue +3 more
openaire +2 more sources
Carbapenem-resistantAcinetobacter baumanniiinfections after organ transplantation
Transplant Infectious Disease, 2010Multi-drug resistant (MDR) gram-negative infections among solid organ transplant (SOT) recipients have long been associated with high morbidity and mortality. Acinetobacter baumannii has emerged as a potent nosocomial pathogen with the recent acquisition of resistance to broad-spectrum beta-lactams, aminoglycosides, fluoroquinolones, and most notably ...
P, Reddy +4 more
openaire +2 more sources